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A qualitative study of patient involvement in medicines management after hospital 
discharge: an under-recognised source of systems resilience  
ABSTRACT 
Introduction There are risks to the safety of medicines management when patient care is 
transferred between healthcare organisations, for example when a patient is discharged 
from hospital. Using the theoretical concept of resilience in healthcare, this study aimed to 
better understand the proactive role that patients can play in creating a safer, resilient 
medicines management at a common transition of care.  
 
Methods Qualitative interviews with 60 cardiology patients six weeks after their discharge 
from two UK hospitals explored patients’ experiences with their discharge medicines. Data 
were initially subjected to an inductive thematic analysis and a subsequent theory-guided 
deductive analysis. 
 
Results During interviews twenty-three patients described medicines management 
resilience strategies in two main themes: identifying system vulnerabilities; and establishing 
self-management strategies. Patients could anticipate problems in the system that supplied 
them with medicines and took specific actions to prevent them. They also identified when 
errors had occurred both before and after medicines had been supplied and took corrective 
action to avoid harm. Some reported how they had not foreseen problems or experienced 
patient safety incidents. Patients recounted how they ensured information about medicines 
changes was correctly communicated and acted upon, and identified their strategies to 
enhance their own reliability in adherence and resource management. 
 
Conclusion Patients experience the impact of vulnerabilities in the medicines management 
system across the secondary-primary care transition but many are able to enhance system 
resilience through developing strategies to reduce the risk of medicines errors occurring. 
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Consequently, there are opportunities – with caveats – to elicit, develop and formalise 
patients’ capabilities which would contribute to safer patient care and more effective 
medicines management. 
 
 
INTRODUCTION 
Despite a continued and worldwide focus on reducing avoidable harm caused to patients by 
healthcare systems, progress has been slow and a widespread reduction in adverse events 
has not materialised.1 2 Furthermore, the under-reporting of errors remains a problem.3 Risks 
to patient safety include those from healthcare systems that manage medicines and 
addressing the level of harm caused by medicines through unsafe practices and errors is an 
established global priority.4 5  
In the UK, medicines management is the system that supports safe and cost-effective 
prescribing, supports patients’ medicines use and helps patients gain the optimum benefit 
from medicines.6 7 The inherent risks in this system are heightened when patient care is 
transferred between healthcare organisations, for example between a hospital and a family 
doctor (in the UK, General Practitioner or GP) when a patient is discharged.8-10 The 
problems that patients experience as a result of how the system operates are well 
documented and include the lack of a definitive list of medicines which can lead to 
discrepancies between lists held by different care providers and the medicines that the 
patient actually takes when they are discharged.11-13 Patients also report not receiving 
sufficient information about their discharge medicines,14 lacking knowledge of their 
medicines,15 17 and becoming confused or experiencing medicines taking as a burden.16 17  
In the UK, the 2013 Berwick Review recommended that patients should be engaged and 
empowered to make healthcare safer.18 UK policy also specifies that patients should have 
the opportunity to be fully involved in the safe management of their medicines when their 
care is transferred and in the reporting of medicines-related patient safety incidents.19 
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Indeed, there is some evidence in recent studies that, despite the complexity of the system, 
patient and family involvement in care transitions may enhance safety and continuity in 
medicines management.20 21 
Resilience in healthcare systems 
Resilience is a protective and proactive system attribute that enables operational 
adjustments before, during or after disturbances or changes so that the system can continue 
functioning.22 23 It values learning from successes – i.e. what went right – as well as from 
failures, such as adverse events. The proactive approach embodied in creating resilience 
contrasts with the reactive approach that retrospectively deconstructs events that have led to 
a loss and then adopts a curative strategy.24 This latter approach is a Safety 1 approach and 
the former proactive approach is categorised as Safety 2, which accepts that successes in 
healthcare are more common than failures.25 Hollnagel outlined the four abilities that 
systems need to be resilient: the ability to respond to events, monitor developments, 
anticipate threats and opportunities, and learn from failures and successes.23  This allows the 
system to know what to expect, how to respond, and how to identify potential opportunities 
to make operational or environmental adjustments. 
In healthcare, the concept of resilience has been used to propose how safety in single 
organisational settings can be enhanced. For example, how clinical handovers of care can 
be improved in individual, micro (e.g. ward level) and macro (organisation wide) contexts 
through foreseeing potential problems and taking action to avoid their impact, coping when  
disruptions occur to prevent them becoming worse, and recovering once disruptions have 
occurred.26 Other studies have explored resilience in the context of how collaborative cross-
checking can reduce the impact of medication errors,27 and how the anticipatory and 
responsive strategies of nuclear medicines technologists could enhance resilience and 
therefore operational safety.28 Resilience theory has also been applied to explore the 
strategies that patients might adopt to avoid unintentional non-adherence to their 
4 
 
medicines,29 but beyond this work the notion of patients as agents of system resilience in 
medicines management has not been explored. 
This study aimed to explore and categorise the proactive medicines safety strategies 
employed by patients discharged from two hospitals. The objectives were to establish an 
understanding of patients’ experiences of the effectiveness of medicines management; to 
understand how patients act proactively in the medicines management system after hospital 
discharge; and to consider the implications for policy and practice based on an analysis of 
patients’ narratives. 
METHODS 
Sample and recruitment 
The sample for this qualitative study consisted of patients discharged with at least one 
medicine from the cardiology wards of two acute UK NHS hospitals in Northern England. 
Cardiology patients were selected as they take numerous medicines, are often prescribed 
new medicines, or experience multiple changes to medicines during hospitalisation. Patients 
were included in the research if they were between 18–80 years of age and were being 
discharged to their own home. A quota sample was developed based on age, socio-
economic status (measured through postcode deprivation level) and gender to offset 
selection bias and promote variation into the sample. The quota guided the targeting of 
patients, particularly towards the end of recruitment. The achieved sample of sixty patients 
was assessed to be sufficient to allow for variations in subgroup experiences. Patients about 
to be discharged were identified on 36 randomly selected days in consultation with ward 
staff. One researcher approached patients and invited them to take part between November 
2013–June 2014. Patients were given a patient information leaflet describing the research 
and their potential involvement. They were given time to read the leaflet and the researcher 
answered their questions about participation. Those who agreed to take part completed a 
consent form. NHS ethics approval was obtained (13/NI/0118). 
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Data collection  
A semi-structured interview schedule explored patients’ experiences of the medicines 
management system from leaving hospital through to six weeks after their discharge and 
their medicines-specific interactions with other people. The schedule was developed by four 
researchers based on a review of the literature about patients’ experiences with their 
medicines at and after hospital discharge. It was then reviewed by a patient representative 
and piloted with three patients, after which it was amended to reduce the potential duration. 
Each interview lasted approximately one hour and was conducted in the patient’s home or 
an alternative venue of their choice. Interviews were audio recorded, transcribed verbatim 
and de-identified. Interviews were conducted by one experienced healthcare researcher 
(BF). 
 
Data analysis 
Interview data for each patient were analysed using inductive thematic analysis,30 to initially 
explore the data. Data were coded by one researcher (BF) and emerging themes were 
discussed by three researchers (BF, GA, AB) two of whom are from healthcare 
backgrounds. During the analysis it became clear that there were considerable data about 
threats to patient safety and the protective actions that patients took. A review of theories 
suggested that the literature about resilience engineering in healthcare would provide a 
useful guide. Therefore a theory-guided deductive analysis was undertaken, taking care to 
ensure the themes directly reflected patients’ experiences.31 Data were then coded into 
themes and subthemes describing patients’ resilience strategies and compared to resilience 
frameworks and typologies. 23 32 33 This approach also informed the terminology for the 
themes. To ensure rigour, the data analysis strategy was developed by two members of the 
research team who then also reviewed the thematic grouping of data. There was an iterative 
process of data extraction, analysis and review. Events recounted by patients that had the 
potential for harm were also extracted and assessed by two researchers from a healthcare 
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background (GA, DN) who discussed the nature of each event guided by the National 
Patient Safety Agency definition and classified it as either a patient safety incident or not.34 
RESULTS 
75 patients were recruited to the study; 15 were lost to follow-up because: they could not be 
contacted (3), they preferred not to take part (3), they felt too ill to continue (6), were not 
available for interview (1) and two patients died. Sixty cardiology patients aged 35–80 were 
interviewed about their post-discharge medicines management experiences. Participants’ 
demographics are shown in Table 1. Twenty-three patients (aged 48–79; 18 male and 5 
female) described strategies to maintain safe and effective medicines management which 
are presented by theme. Data extracts in the form of direct quotes from patients’ interviews 
are included. The main themes identified were: Identifying system vulnerabilities; and 
establishing self-management strategies. Sixteen of the 60 patients also described 
experiencing patient safety incidents.  
Table 1: Characteristics of the study participants 
Sampling variable Categories Participant number 
1. Location Site 1 29    
Site 2 31    
2. Participant age <64    31 
>64    29 
3. Participant gender Male   42  
Female   18  
4. Level of deprivation 
 
 
Low  10   
Medium  18   
High  32   
Total participants 60 60 60 60 
 
 
 
1 Identifying system vulnerabilities 
This theme describes how patients identified system vulnerabilities, experienced patient 
safety incidents and took corrective action. It is presented in three sub-themes: anticipating 
discrepancies; facilitating communication; and responding to errors and safety incidents. 
 
1.1 Anticipating discrepancies 
Patients described the strategies they adopted to ensure they obtained the correct post-
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discharge medicines. They explained how they would compare their post-discharge repeat 
prescription and supplies against the medicines list on their discharge summaries, check the 
medicines they received against those lists or compare the packaging and labels of new 
supplies with their hospital-dispensed medicines. Through these strategies, patients 
demonstrated how they and their informal carers anticipated discrepancies and took the final 
step in verifying that they had been supplied the correct medicines set. 
“I’ve kept the boxes from leaving hospital that the pills were in so [I] just check against them.” 
(Site 1 patient 33) 
 
“[I] just go in [to the community pharmacy] for the tablets… but I always check to see what 
they’ve given me first.” (Site 1 patient 1) 
 
1.2 Facilitating communication 
Patients ensured information from the hospital was communicated in a timely way to their 
primary care team. For example, they would take their hospital discharge summaries to their 
GP or tell their GP directly about the medicines changes made by the hospital. Some did this 
proactively after their discharge – deliberately going to their GP practice to give them details 
– and others did so during appointments.  
Patients described how they would ensure the lists of their medicines held by their care 
providers were correct. For example, they would use their new list of medicines when 
telephoning their GP practice to order repeat medicines, ensuring the reception team were 
aware of changes. Others also took their new medicines lists to their community pharmacy 
which, in the UK, would not normally receive a medicines list from the hospital unless the 
patient was using a pharmacy-prepared compliance aid.  
“[I go to the community pharmacy] with the list [of medicines]. I’ve got my list with me. I write 
a list…I give the pharmacist that…I always double check.” (Site 2 patient 9) 
 
“He [my GP] didn’t know [I was on new medicines] because [he did not have] the letter, the 
discharge notes that the hospital gave me…so I gave him them.” (Site 1 patient 27) 
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“The next time I rang the receptionist and we went through them, she said candesartan was 
still on the receptionists’ list as an available repeat and I said ‘no you can scrub that,’ 
[candesartan had been stopped during admission] so they ended up tidying a couple off.” 
(Site 1 patient 8) 
 
1.3 Responding to errors and safety incidents 
Sixteen patients reported events that we categorised as patient safety incidents. Patients 
discussed how they had unearthed prescribing errors before and after medicines had been 
supplied. They also identified where medicines that were newly prescribed in hospital were 
missing from the sets of medicines they subsequently received. Some patients were able 
respond when they discovered errors and took corrective action. For example, they 
described telephoning their GP practice or community pharmacy to alert them to the 
mistakes that had been made.  
“No, they [my new medicines] weren’t [supplied]. I had to ask for those. They are on [the 
prescription] now and they will be next time.” (Site 2 patient 52) 
Others had not noticed errors before experiencing their impact and were therefore unable to 
take action to mitigate them, for example they took incorrect doses of medicines. It is not 
known whether the system was able to learn and recover from these incidents because 
patients were not aware if the incidents had been reported. 
2 Establishing self-management strategies 
This theme describes how discharged patients would establish or re-establish strategies to 
enhance the reliability of their own medicines management. It is presented in two sub-
themes: post discharge learning and adapting; and implementing adherence cues. 
2.1 Post-discharge learning and adapting 
Some patients explained how they were not given adequate information about their 
medicines in the hospital before being discharged. In response, some patients sought 
information about their medicines from other sources once home, for example from friends 
and family members, some of whom had healthcare experience, the internet or patient 
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information leaflets.  
“I don’t think I was really given information [in the hospital], it was just a matter of, ‘Here are 
your tablets, sod off.’ It’s only when you open the tablets that you read the bit of paper that is 
in with them.”  (Site 1 patient 1) 
“Well [more information] would have been helpful…but I just did it myself. I came home [from 
hospital] and looked on the internet to find out what they [the medicines] were for and what 
they did.” (Site 1 patient 27) 
 
Once home, patients and their informal carers took action to obtain and organise their post-
discharge supplies. Patients arranged collecting their new medicines supplies, for example 
asking family members to collect them. Some patients had created their own spreadsheets 
or tick lists of their medicines, or asked others to do so, and they used these lists to keep 
track of the medicines they had taken or were due to take and to remember their purpose. 
Patients and family members also spent time reorganising the medicines they had been 
given in hospital and their subsequent supplies.  
“She [my wife] does my tablets because they’re little…so it’s easier if I just stand there and 
say they’re for morning and they’re for evening and she’ll put them in my [multi-compartment 
compliance aid].” (Site 1 patient 3) 
 
2.2 Implementing adherence cues 
Patients described how after returning home from hospital they anticipated problems in their 
ability to adhere to their medicines. In response they would establish, re-establish or adapt 
strategies that supported adherence, for example visual or audio cues to help them 
remember to take medicines, such as leaving medicines in a visible place, leaving out a 
glass of water as a reminder to take their medicines, and setting alarms.  
“I mean what I tend to do now is put a glass of water on the table and if I haven’t had it I go, 
‘I haven’t had my tablet….if I haven’t drunk the water I haven’t taken my tablets.’ ”  (Site 2 
patient 18) 
“Well my memory is not that great so now I have a piece of paper with the dates on and I tick 
off when I’ve taken them.” (Site 1 patient 33) 
Patients also asked their family members to remind them to take their medicines, or noted 
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that family members regularly did so without being asked. Others bought and filled weekly 
multi-compartment compliance aids to guard against memory lapses, and some used 
discharge summaries as checklists to fill them. In one case, a patient explained that he and 
his wife struggled to identify their medicines once they had taken them out of their packets in 
order to fill a compliance aid, so his wife helped him to read what was printed on the tablets. 
“Looking at the pills once I’ve got them in these boxes, once you’ve taken them out they’re 
not very easy to identify on their own, and my wife has to have a magnifying glass to see 
them.” (Site 1 patient 4) 
 
“We [my wife and I] had to re-write ourselves a list [of medicines] so we understood…and 
that’s where we ended up buying the box so we had a clear, separation of well what we were 
doing when. Because when you look at a bunch of [medicines] boxes like this, what do you 
do? So we wrote them down on a list and then transferred the list into a box so that you’ve 
got a clear week.” (Site 2 patient 35) 
 
 
DISCUSSION 
This study draws on the experiences of sixty patients after discharge from two hospitals to 
describe how patients and their informal caregivers enhance resilience in a complex system 
and demonstrate that they play a vital role and have valuable insights for safety. As found in 
other studies, our data confirm that the safety of care comes under threat during this care 
transfer and that patients and carers can adopt important roles in the continuity of care.20 21 
35 36 These data also demonstrate how patients’ actions contribute to medicines optimisation 
during care transfers, mapping onto one of the four principles of medicines optimisation – to 
ensure medicines use is as safe as possible.37 Patients’ roles in crucial processes such as 
medicines reconciliation have not been explored in detail in the UK – despite guidelines 
recommending that the patient is spoken to whenever possible during this process,19 and 
evidence from the USA that patients are able to enhance its accuracy following discharge.38 
Like patients and carers in other UK studies, they were able to create medicines charts and 
establish routines after leaving hospital,14 39 which contrasts with the experiences of some 
older patients who have described difficulties adapting routines following hospitalisation,17 
and to understand discharge information.40 It was also clear that informal carers had 
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substantial influence in enhancing resilience, and in common with a recent study, medicines 
management roles were often undertaken by close family members.41 
Patients as agents of system resilience 
Our findings emphasise the need to take into account the proactive current and potential 
roles of patients and their friends and families in identifying, avoiding and reporting system 
vulnerabilities. The basis of resilient system performance rests on four abilities: being able to 
respond to regular and irregular activity or disruption, monitor activity that might affect 
system performance, learn from experience, and anticipate potential disruptions.23 We found 
that patients anticipated potential discrepancies and supply errors and monitored how the 
system supplied them with medicines. They responded when they noticed errors, by 
correcting HCP-held information or reporting errors. As outlined elsewhere,29 patients 
anticipated their own potential adherence problems, and monitored their medicines taking 
through acquiring and using compliance aids and developing or adapting checklists and 
cues.  
We also demonstrated how resilience elements previously described in relation to staff 26 – 
those of foresight, coping, and recovery – were evidenced by many patients in this study. 
Some demonstrated foresight in anticipating problems in the supply of their medicines and 
they were able to mitigate the impact of ‘resident pathogens’ in the system,42 for example, 
well-established but inefficient processes for reconciling medicines. Coping was 
demonstrated by those patients who acted to prevent errors, for example taking action when 
they realised that they had received an incorrect set of medicines. Some who experienced a 
safety incident initiated system recovery through reporting errors. The impact of this recovery 
was less often evidenced, because the timing of the interview – six weeks after discharge – 
did not allow us to collect data about subsequent supplies of medicines.  
Implications for policy and practice and theory 
Enhancing patients’ detection and adaptation strategies at transitions 
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Our findings suggest that bolstering resilience within the medicines system at care transition 
requires a renewed focus on patients’ roles, accepting that many will play a vital part in 
maintaining safety. This begs a question – should patients be prepared to compensate for 
known weaknesses in the system?43 We believe that there is potential in working with 
patients to better understand, enhance and formalise their roles;44-46 whilst acknowledging 
that in some situations patients and their carers may be hesitant about challenging staff,47 or 
believe that their involvement is not valued by staff.36 Methods empowering patients in this 
role can be developed in practice settings, preferably using co-design methods.48 49 Potential 
system modifications to enhance system resilience are shown in Table 2, developed based 
on patients’ experiences described during this study. Modifications could be implemented 
through further co-operation between commissioners, care providers, and patients and 
should be fully evaluated. Commissioners in particular may be unaware of the often unseen 
roles that patients and carers adopt to enhance system safety. There will also likely be cost 
efficiencies in the more effective use of medicines.  
Table 2: Potential system modifications to enhance patient resilience elements adapted from Westrum
33 
and 
Jeffcott et al. 
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Resilience element System modification to enhance patient resilience 
Foresight – to predict, 
foresee and avoid 
adverse events 
 Review guidelines and services, such as the UK’s Medicines 
Optimisation guidelines and the Medicines Use Review service so 
that they support HCPs, patients and carers in working together to 
be active medicines management partners 
 Co-designed enhanced preparation for patients and / or their 
designated nominee to manage medicines once they are 
discharged including help to develop checklists and management 
systems 
 Enhanced guidance about informing HCPs in primary care  about 
medicines changes 
 Preparing patients and carers to ask for help with their medicines 
once back in the community and signposting them to the relevant 
resources 
Coping – adapting and 
preventing situations 
from becoming worse 
 Working with patients and carers to further develop their problem 
solving, for example how to resolve supply errors if they occur and 
to ensure correct medicines are obtained. 
 Preparing and empowering patients and carers to identify patient 
safety incidents and take action should they occur 
Recovery – from an 
adverse event once it 
has occurred 
 Offering clear guidance about how safety incidents can be reported 
 Working with patients and carers to develop effective reporting 
systems capable of operating across care transitions 
 Feedback patient experiences to care providers, commissioners 
and policy makers to enhance system safety 
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Patients and carers can enhance understanding about the safety of the medicines 
management system through their experiences and insight,45 50 and especially valuable 
near-miss intelligence which can play a vital role in enhancing system resilience and 
preventing actual harm through a focus on how an adverse event was prevented.51 Given 
the ability of patients here to recount unsafe care when asked about their experiences 
qualitatively, there may be opportunities to review the way that reporting systems collect 
information about safety incidents – firstly opening the system to patients, and then 
employing the language patients use to capture their concerns.52-55 Such data can be hard to 
collect, for example because patients may feel uncomfortable reporting or challenging the 
care they have received.47 56  
A new perspective on resilience in healthcare 
This is a timely analysis of the role of patients as both policy makers and healthcare 
providers seek to increase public involvement in healthcare; and the patient safety 
movement embraces patient-led preventative approaches. Resilience is a system attribute 
and patients can be viewed as co-operators in that complex system, adapting and 
responding to threats. Resilience in healthcare has previously been described and 
understood mainly from organisational and staff perspectives.26-28 57 This study has thus 
offered an increased understanding of patients as agents of resilience and we have 
highlighted where there are opportunities to strengthen resilience.58 Using resilience as a 
theoretical concept to explore patient interventions to prevent errors has provided a view of 
patients as integral system components, rather than as recipients of treatment in a 
healthcare system. It has also allowed us to explore the system from a positive perspective: 
rather than deconstructing what went wrong for patients we were able to understand how 
things went right for many, despite the evident potential for errors and adverse events. 
Widening the use of this approach has the potential to further empower patients and carers 
as crucial components in healthcare systems through highlighting their positive contributions 
to safety. 
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LIMITATIONS 
This work was conducted with patients discharged from the cardiology wards of two UK 
hospitals; however the transferability of the findings to other patient groups is not clear. A 
member of the research team undertook recruitment and there was a possibility of selection 
bias. Also, if patients felt confident and well enough to take part in the research then they 
may have had more positive experiences than more vulnerable, sicker patients. A more 
extensive study involving multiple sites might enable a broader understanding of patients’ 
proactive roles in maintaining safety, however the sites chosen served areas with highly 
varied demographics and the patients spanned a wide age range. The sample size was 
large for a qualitative study and provided considerable depth and authenticity.59 We also 
analysed the data using the theoretical perspective of resilience as a guide, yet some 
patients did experience the effects of a poorly functioning system and did not demonstrate 
the ability to compensate for errors or rebalance the system, however we were able to report 
this within the presented themes. Finally, the study focussed on patients with one category 
of condition – cardiology; a broader focus on additional conditions may have offered 
alternative experiences, nevertheless cardiovascular disease continues to present a 
significant burden globally.60 
CONCLUSION 
Patients experience the impact of vulnerabilities in the medicines management system 
across the secondary-primary care transition but many patients and their informal caregivers 
are able to enhance system resilience through developing strategies to reduce the risk of 
medicines errors occurring. Consequently, there are opportunities – with caveats – to elicit, 
develop and formalise patients’ capabilities which would contribute to safer patient care and 
more effective medicines management.  
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